In the 1950’s, a group of clinical scientists recognized that, because childhood cancer was a rare disease, no single medical center could study enough patients to make the necessary advances across the spectrum of pediatric oncologic diseases.
Eine wesentliche Triebkraft war die bemerkenswerte und nachhaltige wissenschaftliche Zusammenarbeit.